Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GenSci048 in moderate-to-severe endometriosis-associated pain (Phase IIa, randomized, placebo-controlled)
CTR20251726Phase 2Active
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Oct 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of genakumab in endometriosis, sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Oct 2025; status: active.
02
Drugs
genakumab
03
Conditions
endometriosis
Beyond the preview
Go deeper on CTR20251726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251726.